$ATNM has been on quite the roller coaster the last few days, and I’ve been reading up on market manipulation as a result. I am a newby to investing, but work in the field of databases and dashboards, so I recognize screwy data when I see it, but have no idea how to interpret in […]
Microblogs
Recent Author Comments
Posted on July 15, 2016
Posted on July 14, 2016
I am a little confused about why there is so much doom and gloom here today. We've lived with $ARTH a long time. We lived with it under $0.40 US for at least a year, sometimes down in the teens, but we all believe in the product. Then suddenly it jumpe[...]
Posted on July 8, 2016
Damn autocorrect- I meant Anamorph of course- nice to hear from you.[...]
Posted on July 8, 2016
Hi Anamorphic! Been lurking, but my investments lately have been in medicine- I turned into a kidney stone factory. Very effective for weight loss, but I can't recommend it:-)Hopefully now I've figured out the problem and can get back to spending mon[...]
Posted on July 7, 2016
Well, $0.90 got me- I sold enough to pay for my investment, then filed a new buy order limited to $0.50 for more than 2x the number of shares I sold. I'll hate it if there's no dip to pick up the extra shares, but I've watched most of my portfolio drop so[...]
Posted on July 6, 2016
I have never been able to successfully use search on this site the way I'd like to as I am mostly interested in more recent comments on particular biotech stocks from Dr KSS's articles, and possibly because I access via Safari on iPad. No problem though b[...]
Posted on August 3, 2015
I think the text of the letter sent to stockholders that was published on the SEC Edgar site today was also responsible. I have seen comments on other boards regarding unanswered communication attempts with ATNM management, then a letter with no new infor[...]
Posted on August 3, 2015
The letter text didn't strike me as a positive catalyst. They are presenting at Rodman & Renshaw 17th Annual Global Investment Conference September 9 – September 10, 2015, as is about half the biotechs I'm following. As I understand the process, the P3[...]
Posted on August 3, 2015
$ATNM Better to know- so big thank yous to Tim Fris for setting up the call and Dr. KSS for the terrific analysis. Minimizing bloodshed in an exit strategy seems to be the next step, but this long into "no news" is a terrible time to exit. Do those of y[...]
Posted on July 24, 2015
Apparently the deep dive in share price is due to 3 patients having bradycardia reactions. Any comment?Personally, I am considering renting myself out as a share drop catalyst- I went long yesterday, so the big drop today was predictable. Not the f[...]
Posted on July 20, 2015
Where is the link to the source of your "quotes"? No one is being mean. Look at the posts by highly respected posters: they may include a sentence or two summarizing the content of the source material, but they ALWAYS post the link to the source so ever[...]
Posted on July 11, 2015
Ham handed manipulation trick on $TRVN July 2, 2015: I didn't see this myself, but a contributor to SA posted an article with a screenshot of a NASDAK after hours session where someone at the end of the session sold 1 share for $1, which created a big red[...]
Posted on July 11, 2015
Rodman & Renshaw 2015 Annual Global Inveatment conference lists at least a dozen of our favorite biotechs as presenters- including $ATNM and $ARTH.http://www.nasdaq.com/press-release/rodman--renshaw-2015-annual-global-investment-conference-to-be-held-i[...]
Posted on July 10, 2015
Maybe a case for Titan's implant product? Long $TTNP[...]
Posted on July 9, 2015
I too was deeply grateful for your excellent research on Arch. My view is if you don't examine both pros and cons you are far more likely to face unpleasant consequences. I did not feel like I could say that on the main thread without escalating the tens[...]
Posted on July 1, 2015
Catching up on the thread, so perhaps this was posted in the stuff I haven't gotten to yet- if so sorry for redundancy- but it turns out $ARTH stock can be diluted more, a good deal more, but they got $3m to fund their trials: http://finance.yahoo.com/new[...]
Posted on June 27, 2015
I want to invest in the product very badly, but the management seems focused on dog & pony shows instead of trials. Money is surely key to that, but I don't believe it is all, I also suspect the director may be turning away opportunities from a determinat[...]
Posted on June 27, 2015
Germany's problems in the 20s came from their loss in WWI and the harshness of the terms that ended that war, or so I understand from a very superficial understanding of the history of that period. It was a boom time for the winners, total disaster for th[...]
Posted on June 27, 2015
The situation in China actually scares me more than Greece right now. Thats one hell of a lot of hungry people their government will need to redirect, and they are no longer in the technological Iron Age. Luckily, they are historically not as martially a[...]
Posted on June 24, 2015
The article made it very clear he wondered in from some other sector and tried to apply value techniques. Seemed very surprised by lack of income and assumed we investors just hadn't noticed that lack and would quit buying immediately as soon as a wiser h[...]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info Please note that this is your publicly visible biography - we recommend not including any personal information (phone, email, address, etc.) and ONLY linking to any other pages or profiles you're comfortable sharing with everyone.
$ZFGN and $ESPR are the ones I worry about. The post earlier this week on $ESPR indicating there will be no chance of approval before 2019 and maybe 2022 did disappoint me. Both are way below my cost point, and apparently going to stay that way for a few[...]